60 Degrees Pharmaceuticals (SXTP) Exchange Rate Effect (2023 - 2026)
60 Degrees Pharmaceuticals (SXTP) posted quarterly Exchange Rate Effect of $5942.0 for Q1 2026, up 160.0% year-over-year from $2285.4 in Q1 2025, and up 512.35% quarter-over-quarter from -$1441.0 in Q4 2025.
60 Degrees Pharmaceuticals (SXTP) Exchange Rate Effect (2023 - 2026) Analysis & Trends
60 Degrees Pharmaceuticals (SXTP) has reported Exchange Rate Effect for 4 consecutive years, with $5942.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Exchange Rate Effect rose 160.0% year-over-year to $5942.0; the TTM figure through Mar 2026 stood at $22973.0 (up 367.72% YoY), while the FY2025 annual figure was $7127.0, up 1328.26% from the prior year.
- Exchange Rate Effect climbed to $5942.0 in Q1 2026 per SXTP's latest filing, from -$1441.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $54175.0 in Q4 2023 and bottomed at -$9904.0 in Q1 2025.
- Historically, Exchange Rate Effect has averaged $5801.6 across 4 years, with a median of $1230.0 in 2025.
- On a YoY basis, Exchange Rate Effect climbed as much as 1021.07% in 2025 and fell as far as 1101.94% in 2025.
- 60 Degrees Pharmaceuticals' Exchange Rate Effect stood at $54175.0 in 2023, then sank by 103.68% to -$1993.0 in 2024, then rose by 27.7% to -$1441.0 in 2025, then jumped by 512.35% to $5942.0 in 2026.
- Business Quant data shows SXTP's Exchange Rate Effect at $5942.0 in Q1 2026, -$1441.0 in Q4 2025, and $1230.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.45 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.63 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -287,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | 60 Degrees Pharmaceuticals | 3.00 Mn | 1.98 Mn | 56,798.00 | 2,551.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5,942.00 |
| Mar 31, 2026 | 5,942.00 |
| Dec 31, 2025 | -1,441.00 |
| Dec 31, 2025 | -1,441.00 |
| Sep 30, 2025 | 1,230.00 |
| Sep 30, 2025 | 1,230.00 |
| Jun 30, 2025 | 17,242.00 |
| Jun 30, 2025 | 17,242.00 |
| Mar 31, 2025 | -9,904.00 |
| Mar 31, 2025 | -9,904.00 |
| Dec 31, 2024 | -1,993.00 |
| Dec 31, 2024 | -1,993.00 |
| Sep 30, 2024 | 1,778.00 |
| Sep 30, 2024 | 1,778.00 |
| Jun 30, 2024 | 1,538.00 |
| Jun 30, 2024 | 1,538.00 |
| Mar 31, 2024 | -824.00 |
| Mar 31, 2024 | -824.00 |
| Dec 31, 2023 | 54,175.00 |
| Dec 31, 2023 | 54,175.00 |